There’s been an explosion of interest in women’s health recently. The category, deemed ‘femtech’ by some, is currently a $700m market that’s expected to boom to more than $1 billion by 2025. Of course, women’s health isn’t new, so what, exactly, is different about today's momentum? That’s the question we asked in the latest episode of “License to Accelerate: Perspectives on the Future of Health” that features Jess Graham, chief marketing officer at Hologram Sciences; Bulbul Hooda, brand creator and chief marketing officer at Vella Bioscience; and Michelle Webb who leads the health practice at Allison+Partners. The conversation is moderated by PRovoke Media executive editor Aarti Shah. 03:08 More about Hologram Sciences and Vella Bioscience 06:38 Why we should examine the use of ‘femtech’ 07:21 Medical terms vs. euphemisms for women’s health 10:16 Social media restrictions on feminine health 13:49 How to build trust around such intimate offerings 17:48 Inclusive storytelling on women’s health 21:26 How data is driving storytelling on women’s health 24:16 Combating ageism against women 27:10 Where is the conversation headed? 29:40 How to stand out in such a crowded, buzz-generating space?

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related